查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301153

灌注系統市場規模、份額和趨勢分析報告：按應用、按地區、細分市場趨勢，2023-2030 年

Perfusion Systems Market Size, Share & Trends Analysis Report By Application (Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-vivo Organ Perfusion System), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

灌注系統市場增長和趨勢

預計到 2030 年，全球灌注系統市場規模將達到 15 億美元。

此外，預計 2023 年至 2030 年該市場將以 4.7% 的複合年增長率增長。 慢性病的流行、器官移植的增加和多器官衰竭等因素預計將推動市場增長。 此外，對細胞研究的投資增加和生物製品製造的增加預計將進一步推動灌注系統行業的增長。

疫情上半年，灌注系統銷量直線下降。 世界各國政府的封鎖和限制導致去醫院就診的患者減少、手術減少以及研發活動放緩。 然而，隨著政府和醫務人員加大力度遏制病毒傳播並為未來類似事件做好準備，預計市場將在 2021 年反彈並在預測期內達到峰值。

灌注系統市場報告亮點

  • 灌注系統市場按應用細分為心肺灌注系統、細胞灌注系統和離體器官灌注系統。 由於全球心髒病患病率較高，心肺灌注系統將在 2022 年佔據市場主導地位
  • 按地區劃分，2022 年北美市場份額最高。 慢性病的增加、醫療保健行業的成熟以及器官捐獻者數量的增加正在推動該地區的市場增長。
  • COVID-19 大流行對灌注系統市場產生了重大負面影響。 醫療保健優先事項的轉變、社會疏遠和全球封鎖等因素導致手術減少以及器官捐獻和移植減少。
  • 冠狀病毒大流行減少了灌注系統的銷量，但在第一波大流行過去後，市場預計將在預測期內復蘇並達到新冠疫情前的增長水平。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 調查方法
  • 信息獲取
  • 信息或數據分析
  • 市場形成和驗證
  • 型號詳細信息
  • 輔助信息列表
  • 主要信息列表
  • 目的

第 2 章執行摘要

  • 市場前景
  • 分部展望
  • 競爭考慮因素

第 3 章灌注系統市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/輔助市場前景
  • 採用和增長前景圖
  • 行業價值鏈分析
    • 報銷框架
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 灌注系統市場分析工具
    • 行業分析-波特分析
    • PESTEL 分析
    • 主要交易和戰略聯盟分析
    • 市場進入策略

第 4 章灌注系統：應用估算和趨勢分析

  • 定義和範圍
    • 心肺灌注系統
    • 細胞灌注系統
    • 離體器官灌注系統
  • 2021 年和 2030 年產品市場份額
  • 細分儀表板
  • 按應用劃分的全球灌注系統市場前景
  • 2018-2030 年以下市場規模、預測和趨勢分析
    • 心肺灌注系統
    • 細胞灌注系統
    • 體外灌注系統

第五章灌注系統市場：區域估計和趨勢分析

  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2022 年區域市場份額和主要參與者
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按因素進行 SWOT 分析（政治/法律、經濟/技術）
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030 年市場規模、預測、數量和趨勢分析：
  • 北美
    • 2018-2030 年市場預估和預測（收入）
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 俄羅斯
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • 沙特阿拉伯
    • 南非
    • 阿拉伯聯合酋長國

第 6 章競爭格局

  • 主要市場進入者的最新趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商情況
    • 主要經銷商和渠道合作夥伴名單
    • 主要客戶
    • 2022 年主要參與者的市場份額分析
    • Getinge AB
    • Medtronic, plc.
    • LivaNova,.
    • Terumo Corporation
    • Nipro Corporation
    • XENIOS AG
    • Repligen Corporation
    • Spectrum Laboratories, Inc.
    • Merck KGaA.
    • Harvard Bioscience, Inc.
    • ALA Scientific Instruments, Inc.
    • Lifeline Scientific, Inc.
    • XVIVO Perfusion AB
Product Code: GVR-1-68038-470-3

Perfusion Systems Market Growth & Trends

The global perfusion systems market size is projected to reach USD 1.5 billion by 2030, according to a new report by Grand View Research, Inc. Furthermore, the market is projected to advance at a CAGR of 4.7% from 2023 to 2030. Factors such as the growing prevalence of chronic diseases and the rise in the number of organ transplants and multiple organ failures are anticipated to boost the market growth. In addition, increasing investments in cell-based research and a rise in biologics manufacturing are further expected to impel the growth of the perfusion system industry.

There was a steep downfall in the sales of perfusion systems during the first half of the pandemic. The lockdowns and restrictions imposed by governments globally resulted in reduced patient visits to hospitals, a reduced number of surgeries, and a slowdown in R&D activities. However, with the increasing efforts of the government and healthcare professionals to curb the spread of the virus and prepare for similar events in the future, the market began to recover in 2021 and is expected to flourish during the forecast period.

Perfusion Systems Market Report Highlights

  • Based on application, the perfusion systems market is segmented into cardiopulmonary perfusion system, cell perfusion system, and ex-vivo organ perfusion system. The cardiopulmonary perfusion system dominated the market in 2022 due to the high prevalence of cardiac diseases globally
  • In terms of region, North America accounted for the highest market share in 2022. The rising incidences of chronic disorders, a well-established healthcare sector, and a rise in the number of organ donors are driving the regional market growth
  • The COVID-19 pandemic had a significant negative impact on the market for perfusion systems. Factors such as the change in healthcare priorities, social distancing, and global lockdowns resulted in a reduced number of surgeries and a fall in the number of organ donations and transplants
  • The coronavirus outbreak led to a decline in the sales of perfusion systems; however, post the first wave of the pandemic, the market recovered and is expected to reach its pre-COVID growth level during the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Technology
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Material outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Perfusion System Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of cardiovascular and respiratory diseases
      • 3.4.1.2. Rising number of organ transplantations
      • 3.4.1.3. Growth in Aging Population, Increasing Incidence of Multiple Organ Failures
      • 3.4.1.4. Government and NGO Initiatives to Encourage Organ Donation
      • 3.4.1.5. Increasing Investments in Cell - Based Research
      • 3.4.1.6. Increase in Biologic Manufacturing
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High Cost of Organ Transplantation
      • 3.4.2.2. Ethical Concerns and High Cost of Cell - Based Research
  • 3.5. Perfusion System Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Perfusion System: Application Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Cardiopulmonary Perfusion System
    • 4.1.2. Cell Perfusion System
    • 4.1.3. Ex - Vivo Organ Perfusion System
  • 4.2. Product Market Share, 2021 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Perfusion System Market by Application Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Cardiopulmonary Perfusion System
      • 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.2. Oxygenators
      • 4.5.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.3. Heart - Lung Machine
      • 4.5.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.4. Perfusion Pumps
      • 4.5.1.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.5. Cannula
      • 4.5.1.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.6. Monitoring System
      • 4.5.1.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.7. Others
      • 4.5.1.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Cell Perfusion System
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.2. Bioreactor Perfusion System
      • 4.5.2.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.3. Microfluidic Perfusion System
      • 4.5.2.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.4. Gravity/Pressure - driven Perfusion System
      • 4.5.2.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.5. Small Mammal Organ Perfusion System
      • 4.5.2.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Ex - vivo Perfusion System
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.3.2. Hypothermic Perfusion System
      • 4.5.3.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.3.3. Normothermic Perfusion System

Chapter 5. Perfusion System Market: Regional Estimates & Trend Analysis

  • 5.1. Regional market share analysis, 2022 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Regional Market Share and Leading Players, 2022
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa
  • 5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East and Africa
  • 5.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 5.7. North America
    • 5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. U.S.
      • 5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. Canada
      • 5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.8. Europe
    • 5.8.1. U.K.
      • 5.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.2. Germany
      • 5.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.3. France
      • 5.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.4. Italy
      • 5.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.5. Spain
      • 5.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.6. Russia
      • 5.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.9. Asia Pacific
    • 5.9.1. China
      • 5.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.2. Japan
      • 5.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.3. India
      • 5.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.4. Australia
      • 5.9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.5. South Korea
      • 5.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.6. Singapore
      • 5.9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.10. Latin America
    • 5.10.1. Brazil
      • 5.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.10.2. Mexico
      • 5.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.10.3. Argentina
      • 5.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.11. MEA
    • 5.11.1. Saudi Arabia
      • 5.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.11.2. South Africa
      • 5.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.11.3. UAE
      • 5.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2022
    • 6.3.4. Getinge AB
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Medtronic, plc.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. LivaNova,.
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Terumo Corporation
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Nipro Corporation
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. XENIOS AG
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Repligen Corporation
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Spectrum Laboratories, Inc.
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Merck KGaA.
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Harvard Bioscience, Inc.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. ALA Scientific Instruments, Inc.
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. Lifeline Scientific, Inc.
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Product benchmarking
      • 6.3.15.4. Strategic initiatives
    • 6.3.16. XVIVO Perfusion AB
      • 6.3.16.1. Company overview
      • 6.3.16.2. Financial performance
      • 6.3.16.3. Product benchmarking
      • 6.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 5 Canada perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 6 Europe perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 7 Europe perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.K. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 10 France perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 11 Italy perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 12 Spain. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 13 APAC. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 14 APAC perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 15 China perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 16 Japan perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 17 India perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 18 Latin America. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 19 Latin America perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 20 Brazil. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 21 Mexico perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 22 Argentina. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 23 Middle East and Africa. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 24 Middle East and Africa perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 25 South Africa. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 26 Saudi Arabia perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 27 UAE. perfusion system market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value - chain - based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Perfusion System: market outlook
  • Fig. 14 Perfusion System competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Perfusion System market driver impact
  • Fig. 20 Perfusion System market restraint impact
  • Fig. 21 Perfusion System market strategic initiatives analysis
  • Fig. 22 Perfusion System market: application movement analysis
  • Fig. 23 Perfusion System market: application outlook and key takeaways
  • Fig. 24 Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 25 Cardiopulmonary Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 26 Oxygenators market estimates and forecast, 2018 - 2030
  • Fig. 27 Heart - Lung Machine market estimates and forecast, 2018 - 2030
  • Fig. 28 Perfusion Pumps market estimates and forecast, 2018 - 2030
  • Fig. 29 Cannula market estimates and forecast, 2018 - 2030
  • Fig. 30 Monitoring Systems market estimates and forecast, 2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Cell Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 33 Bioreactor Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 34 Microfluidic Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 35 Gravity/Pressure - driven Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 36 Small Mammal Organ Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 37 Ex - Vivo Organ Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 38 Hypothermic market estimates and forecast, 2018 - 2030
  • Fig. 39 Normothermic market estimates and forecast, 2018 - 2030
  • Fig. 40 Global Perfusion System market: regional movement analysis
  • Fig. 41 Global Perfusion System market: regional outlook and key takeaways
  • Fig. 42 Global market share and leading players
  • Fig. 43 North America market share and leading players
  • Fig. 44 Europe market share and leading players
  • Fig. 45 Asia Pacific market share and leading players
  • Fig. 46 Latin America market share and leading players
  • Fig. 47 Middle East & Africa market share and leading players
  • Fig. 48 North America: SWOT
  • Fig. 49 Europe SWOT
  • Fig. 50 Asia Pacific SWOT
  • Fig. 51 Latin America SWOT
  • Fig. 52 MEA SWOT
  • Fig. 53 North America, by country
  • Fig. 54 North America
  • Fig. 55 North America market estimates and forecast, 2018 - 2030
  • Fig. 56 U.S.
  • Fig. 57 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 58 Canada
  • Fig. 59 Canada market estimates and forecast, 2018 - 2030
  • Fig. 60 Europe
  • Fig. 61 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 62 U.K.
  • Fig. 63 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 64 Germany
  • Fig. 65 Germany market estimates and forecast, 2018 - 2030
  • Fig. 66 France
  • Fig. 67 France market estimates and forecast, 2018 - 2030
  • Fig. 68 Italy
  • Fig. 69 Italy market estimates and forecast, 2018 - 2030
  • Fig. 70 Spain
  • Fig. 71 Spain market estimates and forecast, 2018 - 2030
  • Fig. 72 Russia
  • Fig. 73 Russia market estimates and forecast, 2018 - 2030
  • Fig. 74 Asia Pacific
  • Fig. 75 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 76 China
  • Fig. 77 China market estimates and forecast, 2018 - 2030
  • Fig. 78 Japan
  • Fig. 79 Japan market estimates and forecast, 2018 - 2030
  • Fig. 80 India
  • Fig. 81 India market estimates and forecast, 2018 - 2030
  • Fig. 82 Thailand
  • Fig. 83 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecast, 2018 - 2030
  • Fig. 86 Australia
  • Fig. 87 Singapore market estimates and forecast, 2018 - 2030
  • Fig. 88 Latin America
  • Fig. 89 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 90 Brazil
  • Fig. 91 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 92 Mexico
  • Fig. 93 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 94 Argentina
  • Fig. 95 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 96 Middle East and Africa
  • Fig. 97 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 98 Saudi Arabia
  • Fig. 99 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 100 South Africa
  • Fig. 101 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 102 UAE
  • Fig. 103 UAE market estimates and forecast, 2018 - 2030
  • Fig. 104 Participant categorization - Perfusion System market
  • Fig. 105 Market share of key market players - Perfusion System market